Clinical Features	Time to Death		AGE		NEOPLASM.DISEASESTAGE		PATHOLOGY.T.STAGE		PATHOLOGY.N.STAGE		PATHOLOGY.M.STAGE		GENDER		HISTOLOGICAL.TYPE		RADIATIONS.RADIATION.REGIMENINDICATION		RADIATIONEXPOSURE		EXTRATHYROIDAL.EXTENSION		COMPLETENESS.OF.RESECTION		NUMBER.OF.LYMPH.NODES		MULTIFOCALITY		TUMOR.SIZE	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	t-test_P	t-test_Q	Chi-square test_P	Chi-square test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	t-test_P	t-test_Q
NRAS	34 (9%)	360	0.46458	1	0.44433	1	0.04705	1	0.14843	1	0.00013829	0.0118	0.49058	1	1	1	4.6212e-05	0.00402	0.61051	1	1	1	0.18938	1	0.65718	1	5.5343e-05	0.00476	0.36883	1	0.6495	1
BRAF	237 (60%)	157	0.91236	1	0.62443	1	0.0015744	0.129	0.00041041	0.0341	0.00029483	0.0248	0.10604	1	0.34694	1	2.1955e-19	1.95e-17	0.032298	1	0.59307	1	2.4181e-07	2.13e-05	0.39191	1	0.54231	1	0.83436	1	0.36978	1
HRAS	13 (3%)	381	0.50865	1	0.59232	1	0.471	1	0.43636	1	0.54905	1	0.28501	1	0.74706	1	0.012525	1	1	1	1	1	0.69076	1	0.17529	1	0.51305	1	0.77876	1	0.95526	1
EIF1AX	6 (2%)	388	0.095036	1	0.13757	1	0.96625	1	1	1	0.62505	1	0.47292	1	0.1781	1	0.072681	1	1	1	1	1	1	1	0.28556	1	0.77238	1	0.66809	1	0.69089	1
NUP93	4 (1%)	390	0.90996	1	0.40982	1	0.77674	1	0.73545	1	0.34799	1	0.65839	1	1	1	0.014541	1	1	1	1	1	1	1	0.52246	1	0.60849	1	0.34364	1	0.98452	1
NLRP6	3 (1%)	391	0.64979	1	0.032685	1	0.81105	1	0.16898	1	0.60473	1	0.13418	1	1	1	0.65738	1	1	1	1	1	1	1	1	1	0.52437	1	0.60117	1	NA	NA